Literature DB >> 30391483

Development of a novel thermal-sensitive multifunctional liposome with antibody conjugation to target EGFR-expressing tumors.

Kuan-Chieh Liu1, Arundhathi Arivajiagane1, Shang-Jung Wu1, Shey-Cherng Tzou1, Chiao-Yun Chen2, Yun-Ming Wang3.   

Abstract

A novel EGFR-targeting, thermal-sensitive multifunctional liposome (TSML) was developed based on manganese-doped magnetism-engineered iron oxide nanoparticles (MnMEIOs) and gold nanorods (AuNRs) for efficient photothermal therapy and magnetic resonance (MR) imaging. An Erbitux-conjugated TSML (Erb-TSML) was encapsulated with doxorubicin and gold nanorods conjugated with manganese-doped magnetism-engineered iron oxide nanoparticles, for theranostic applications of EGFR-positive tumors. The Erb-TSML selectively targeted EGFR-positive tumors and promoted tumor destruction by laser activation. Using confocal microscopy, MR and optical imaging, we demonstrated that Erb-TSML specifically bound to A431 tumor cells. No signs of major morphological damages to the normal tissues were observed in mice treated with Erb-TSML and laser, indicating this theranostic platform protected heart against doxorubicin-induced toxicity to normal tissues. These results indicate that the Erb-TSML may be a promising diagnostic and therapeutic platform for EGFR-overexpressing tumors.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  AuNR@MnMEIO; Doxorubicin; EGFR; Erbitux; MRI; TSML

Mesh:

Substances:

Year:  2018        PMID: 30391483     DOI: 10.1016/j.nano.2018.10.006

Source DB:  PubMed          Journal:  Nanomedicine        ISSN: 1549-9634            Impact factor:   5.307


  10 in total

1.  Effect of Cholesterol on Nano-Structural Alteration of Light-Activatable Liposomes via Laser Irradiation: Small Angle Neutron Scattering Study.

Authors:  Zheng Yuan; Saikat Das; Changwoo Do; Yoonjee C Park
Journal:  Colloids Surf A Physicochem Eng Asp       Date:  2022-02-09       Impact factor: 4.539

2.  AS1411 aptamer-modified theranostic liposomes co-encapsulating manganese oxide nano-contrast agent and paclitaxel for MRI and therapy of cancer.

Authors:  Jingjing Li; Qing Li; Meijuan He; Fan Ding; Lulu Cai; Mingming Zhao; Lina Dong; Qi Wang; Kai Xu
Journal:  RSC Adv       Date:  2019-10-29       Impact factor: 4.036

Review 3.  Novel Tumor-Targeting Nanoparticles for Cancer Treatment-A Review.

Authors:  Adelina-Gabriela Niculescu; Alexandru Mihai Grumezescu
Journal:  Int J Mol Sci       Date:  2022-05-08       Impact factor: 6.208

Review 4.  Hybrid Nanosystems for Biomedical Applications.

Authors:  Joshua Seaberg; Hossein Montazerian; Md Nazir Hossen; Resham Bhattacharya; Ali Khademhosseini; Priyabrata Mukherjee
Journal:  ACS Nano       Date:  2021-01-26       Impact factor: 18.027

5.  Specific drug delivery efficiently induced human breast tumor regression using a lipoplex by non-covalent association with anti-tumor antibodies.

Authors:  Yu-Ling Lin; Nu-Man Tsai; Chia-Hung Chen; Yen-Ku Liu; Chung-Jen Lee; Yi-Lin Chan; Yu-Shan Wang; Yuan-Ching Chang; Chi-Hsin Lin; Tse-Hung Huang; Chao Ching Wang; Kwan-Hwa Chi; Kuang-Wen Liao
Journal:  J Nanobiotechnology       Date:  2019-02-06       Impact factor: 10.435

6.  Functionalized silk spheres selectively and effectively deliver a cytotoxic drug to targeted cancer cells in vivo.

Authors:  Anna Florczak; Tomasz Deptuch; Anna Lewandowska; Karolina Penderecka; Elzbieta Kramer; Andrzej Marszalek; Andrzej Mackiewicz; Hanna Dams-Kozlowska
Journal:  J Nanobiotechnology       Date:  2020-12-01       Impact factor: 10.435

Review 7.  MRI-traceable theranostic nanoparticles for targeted cancer treatment.

Authors:  Tareq Anani; Shiva Rahmati; Nayer Sultana; Allan E David
Journal:  Theranostics       Date:  2021-01-01       Impact factor: 11.556

8.  Does conjugation strategy matter? Cetuximab-conjugated gold nanocages for targeting triple-negative breast cancer cells.

Authors:  S Avvakumova; L Pandolfi; E Soprano; L Moretto; M Bellini; E Galbiati; M A Rizzuto; M Colombo; R Allevi; F Corsi; A Sánchez Iglesias; D Prosperi
Journal:  Nanoscale Adv       Date:  2019-07-23

Review 9.  Stimuli-responsive nanocarriers for drug delivery, tumor imaging, therapy and theranostics.

Authors:  Peng Mi
Journal:  Theranostics       Date:  2020-03-15       Impact factor: 11.556

10.  Manganese in Diagnostics: A Preformulatory Study.

Authors:  Maddalena Sguizzato; Walter Pula; Anna Bordin; Antonella Pagnoni; Markus Drechsler; Lorenza Marvelli; Rita Cortesi
Journal:  Pharmaceutics       Date:  2022-01-03       Impact factor: 6.321

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.